Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, and addressing current medical needs.

Avantor, Inc. (NYSE: AVTR) has announced an expanded partnership with the National Institute for Bioprocessing Research and ...

In a review paper published in Molecular Biomedicine, an international team of scientists comprehensively: (1) highlight the fundamentals of mAbs-development and optimization technologies, (2) focus ...

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on cost-effective therapies.

It is essential to increase the number of autonomous agents in bioprocess development for biopharma innovation.

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...

MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment ...

R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins ...

The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...

The global upstream bioprocessing equipment market was valued at approximately US$ 7.75 billion in 2022 and is expected to ...

This study is led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University).